background: Deletion of the entire AZFb interval from the Y chromosome is strictly associated with azoospermia arising from maturation arrest during meiosis. Here, we describe the exceptional case of an oligozoospermic man, 13-1217, with an AZFb + c (P5/distal-P1) deletion. Through the characterization of this patient, and two AZFb (P5/proximal-P1) patients with maturation arrest, we have explored three possible explanations for his exceptionally progressive spermatogenesis.
Introduction
The analysis of the Y chromosome in infertile men has identified three azoospermia factor intervals (AZFa, b and c) that contain genes critical for efficient spermatogenesis (Ma et al., 1992; Reijo et al., 1995; Vogt et al., 1996) . Complete deletion of each AZF deletion interval is associated with a characteristic phenotype described in 1996 (Vogt et al., 1996) , and these correlations have stood the test of time. The AZFa deletion is associated with small testes lacking germ cells and azoospermia. The AZFb deletion is also associated with azoospermia, but this is a consequence of maturation arrest during the first meiotic prophase. In cases of AZFb deletion, the germ cells from mitotic (spermatogonia) and early meiotic stages (primary spermatocytes) remain abundant in all tubules, but post-meiotic stages (spermatid) are rarely seen, and there is always a complete absence of elongating spermatids and spermatozoa (Girardi et al., 1997; Krausz et al., 2000; Hopps et al., 2003) . The AZFc deletion is associated with a reduction in spermatogenic activity (hypospermatogenesis) that leads to cryptozoospermia or azoospermia in the majority of cases but can occasionally be associated with higher sperm counts (.1 × 10 6 /ml) (Girardi et al., 1997; Oates et al., 2002; Hopps et al., 2003) . The AZFb deletion interval, critical for efficient progression through meiosis into spermiogenesis, extends from the P5 palindrome to the P1.2 palindrome within the proximal arm of the P1 palindrome in the AZFc interval (Repping et al., 2002) . Classic AZFb deletions, also known as P5/proximal-P1, are 6.2 megabases (Mb) in extent, remove 32 transcription units and occur mainly by unequal crossing over between homologous segments at their extremities. A larger deletion, P5/distal-P1, also occurs between P5 and the P1.1 palindrome in the distal arm of P1 (7.7 Mb) which in addition results in the loss of almost the entire AZFc interval. The proximal breakpoint of both deletion types is invariably situated between the two CDY2 genes, but can vary in position, being found in either arm of P5 or in the spacer at the centre of the palindrome.
One consequence of the maturation arrest associated with complete AZFb deletion is that post-meiotic stages are absent. Currently, the diagnosis of an AZFb deletion in an azoospermic man has considerable prognostic value within the context of an intracytoplasmic sperm injection (ICSI) protocol, since it shows that there is no chance of recovering testicular spermatozoa, and that extensive testicular biopsies are therefore unnecessary (Krausz et al., 2000) . However, in this report, we present a patient, who represents the first case in which a complete AZFb deletion is associated with complete spermatogenesis. The exceptional spermatogenesis in this patient is evident not only from his spermogram, but also from the immunocytochemical analysis of synapsis in meiotic germ cells, the expression of post-meiotic germ cell markers and the immunofluorescent detection of spermatids in a testicular biopsy. Understanding why this patient is exceptional should provide fresh insights into the functions of the human Y chromosome during spermatogenesis.
With the objective of understanding the basis of this exceptional phenotype, we have investigated three plausible explanations. Firstly, because of unique deletion breakpoints, the patient may retain expression of the AZFb gene required for meiosis. Secondly, he could be a mosaic, with post-meiotic germ cells developing from a line with an intact Y chromosome. Thirdly, he may carry alleles of other Y chromosome genes that reduce the stringency of the meiotic block induced by the AZFb deletion.
Materials and Methods

Patients
Patient 13-1217 was 30 when he was referred to the Marseille reproductive centre at because of primary infertility. Karyotype analysis revealed the presence of the Yq12 heterochromatin but a reduction in the size of the Yq euchromatin, suggesting an interstitial deletion of Yq. His karyotype was otherwise normal. An entirely normal karyotype was found in his father. The patient was phenotypically normal, but had been treated with the tranquilizers Laroxyl (Amitriptyline) and Lysanxia (Prazepam) for obsessional neurosis. Genital examination revealed a moderate bilateral testicular hypotrophy; follicle stimulating hormone (FSH) level 12.7 IU/l, luteinizing hormone (LH) 5.56 IU/l, Testosterone 4.46 ng/ml. A first spermiogram showed a sperm concentration of 1 × 10 6 spermatozoa/ml with rare spermatids. However, a second spermiogram, 1 year later, showed azoospermia. A third spermiogram, 5 months after the second, again showed azoospermia with rare spermatids. The patient had not begun tranquilizer treatment at the time of the first spermiogram, was under treatment for the second and had just stopped prior to the third. A testicular biopsy was then conducted with a view to performing an ICSI, but no spermatozoa were obtained. The couple successfully pursued their desire to have a child by fertilization with donated sperm. Patient 13-5349 was described in detail previously (Perrin et al., 2006) . He is azoospermic and was shown to have maturation arrest during early stages of pachynema. He carries a P5/P1-proximal AZFb deletion of the Y chromosome.
Patient StE-363 was recruited from the St. Etienne reproductive centre. He has a normal karyotype, and was phenotypically normal. Testes and the urogenital tract in general were normal. Hormonal assessment was normal: FSH 5.0 IU/l LH 8.1 IU/l, testosterone 4.28 ng/ml and inhibin B 109 pg/ml. Sperm parameters were determined when he was 28 years old revealing him to be azoospermic and no spermatozoa were found in a testicular biopsy. Histological examination revealed a maturation arrest at the spermatocyte stage.
Controls used in meiotic study
Testicular material was obtained from one normal 75-year-old patient and eight azoospermic or severely oligozoospermic individuals with ages ranging from 24 to 46 years. The normal patient had undergone orchydectomy as part of the treatment for prostatic carcinoma. Among the infertile patients, three had an obstructive infertility with a normal karyotype and normal FSH levels; five had a non-obstructive infertility with a normal karyotype and FSH levels were higher than 10 UI/l in two patients. All the infertile patients underwent testicular biopsy either as part of their infertility evaluation or to recover testicular spermatozoa for ICSI.
Genomic PCR
We initially determined 13-1217 and 13-5349 to be negative for the AZFb markers sY113ii, sY117, sY121, sY122, sY123, sY124, sY125, sY126, sY127, sY128, sY132 and sY134. In addition, 13-1217 is deleted for sY254 (DAZ), sY153, sY154, sY155, sY148, sY220, sY1206 as well as BPY2, but not sY158 or CDY1 (confirmed with sY639). StE-363 was shown to be negative for sY117, sY1015, sY127, sY134, sY135, sY143, sY142, sY1197 and sY1192. These markers have been described previously: BPY2 and CDY1 (Saut et al., 2000) and all others (Vollrath et al., 1992; Reijo et al., 1995; Repping et al., 2003) .
Breakpoints were further localized using STS markers for Y landmarks as numbered in Fig. 2: (1) Proximal external boundary of P5 sY1264; (2) CDY2 o621: gACATTAGTGGGTGCATC and o622: gACCTCAAGAA AACTGTGAG-578C;(3) proximal P5 spacer o1278: cATTCACACCC CAGGTCTGC and o1279: gTTCTGTTCCGGTTGCCATG-588C and sY1227; (4) distal P5 spacer o1280: gGGCATAAGGCGGTTTCTGC and o1281: gATTGACTAATCCTGCTCAAGG-608C and sY1228; (5) P5-P4 junction o1717: cTTTCTCTTTTGGGCATTTAGTGC and o1718: gAACATTTAGGAGCAGGCTG-608C and sY1224; (6) DAZ sY254; (7) P2-P1 junction sY1291; (8) P1.1 and P1.2 spacer o1488: cGGCTC TTTTGACAATGTCCAC and o1485: aCAACTGTAAGTTGCAGGT CAG-648C and (9) Chromosome 15 homology adjacent to P1.1/P1.2 o1282: cTAGACCAGACTACTGAATACC and o1283: gCCTTAAGCA GGGAATCATG-608C and sY1257. The Y landmark markers sY1224, sY1227, sY1228, sY1257 and sY1264 are as described in Repping et al. (2002) . All these PCRs were run under the standard conditions.
The PCR amplifications used to localize the distal breakpoint to P1.1 were performed with Expand High Fidelity (Roche). The breakpoint itself was amplified using the Expand High Fidelity Taq polymerase. The primers used were o1486: aGAGTGCTTGACCACTGAC, o1497: cTC TTAAGCTTCCCACATACC, o1499: tCATGAGTCACACAGCGTAC, o1502: aTGTCAGTGGTCAAGCACTC and o1504: gTTGAGTGATG TACGCTGTGTG. The annealing temperature for these long-range PCRs was 588C. Elongation times for different primer pairs were as follows: 8 min-o1486/o1497, 4 min-o1486/o1499, 8 min-o1502/ o1499 and 10 min-o1502/o1497.
Genomic mosaicism was tested on genomic DNA using RBMY1 (seven copies) o2764: tGCAAGAGGGCCTCGGATG and o2763: aTCACCA CAGCTCGAGTAAC-608C, and intron5/exon6 of DAZ (seven copies) o2805: gACTTCAGGTGTTTACCCAAG and o2806: gATTTGGGGCT GCAGGTAGG-608C.
The Y haplogroup was determined to be HgL, using a PCR-RFLP test for SNP marker M185 (o1867: gAGTACCTATCACTGAATGTGC and o1868: aGGAGCAAGTTACCTAGAGAC-568C-HaeIII cuts the ancestral state). Many Y binary markers map within the AZFb interval and therefore could not be used. However, the other markers we did test are HgE-SRY4064 (ancestral), HgF-M213 (derived), HgG-M201 (ancestral), HgI-M170 (ancestral), HgJ-12f2 (ancestral), HgM-M189 (ancestral), HgNO-M214 (ancestral), HgP-92R7 (ancestral).
Meiotic study
Bilateral testicular biopsy was obtained under general anaesthesia from azoospermic men with no epididymal sperm. All biopsies were first teased apart to retrieve sperm for ICSI, and meiotic study was performed on the remaining dilute cellular suspension. This suspension was treated as previously described (Metzler-Guillemain and Guichaoua, 2000) . Briefly, after centrifugation, the pellet was resuspended in Ham F-10/10% glycerol, aliquoted in 1 ml cryotubes and frozen in liquid nitrogen.
Cytospin spread
One cryotube was rapidly thawed at 378C; 200 ml of the cell suspension was spread on one microscope slide, by cytocentrifugation with a cytospin 2 (Shandon) at 280g for 5 min, and giemsa stained. To obtain well-spread spermatocytes, the cellular concentration was adjusted by dilution in HamF-10/10% glycerol, based on analysis of a first giemsa stained slide. Slides were then produced by cytocentrifugation of this diluted suspension and prepared for immunocytochemistry.
Immunocytochemical technique
A rabbit polyclonal antibody, kindly provided by P.B. Moens, that recognizes the SYCP3 protein of the axial/lateral elements of the synaptonemal complex (SC) was applied to spreads. Centromeres were localized by an anti-kinetochore antibody from sera of patients with CREST syndrome (Calcinosis, Raynaud's phenomenon, Esophageal dysmotility, Sclerodactyly, Telangiectasiae) at a titre of 1/1000 (determined by using indirect immunofluorescence on an HP2 cell line as substrate) used at a dilution of 1/20 in phosphate-buffered saline (PBS). After 3 × 5 min washes in PBS with 0.4% photo-flo 200 (Kodak), two secondary antibodies (Sigma) were applied: fITC-conjugated goat anti-rabbit IgG at a dilution of 1/200 in PBS and a TRITC-conjugated anti-human IgG at a dilution of 1/16 in PBS for 1 h at 378C. Slides were washed twice for 5 min in PBS with 0.4% photo-flo 200 and 2 times 1 min in dH 2 O with 0.4% photo-flo 200. Preparations were mounted in antifade (Q-BIOgene, France) and preserved at 48C.
Microscope analysis
Microscope analysis was performed on a Zeiss Axioplan 2 photomicroscope (Karl Zeiss, Oberkochen, Germany), and with a confocal scanner Leica TCS 4D mounted on a Leica DMIRBE microscope (Leica, Heidelberg, Germany). All immunostained pachytene nuclei present on the preparations were analysed without applying selection criteria.
Immunofluorescent analysis of testis biopsy with anti-SPACA1 antibody
The cell suspension from the lacerated testicular fragment was spread onto poly-L-lysine coated slides by cytocentrifugation at 44g for 5 min. The cells were then fixed in 4% paraformaldehyde, 1 × PBS for 10 min, rinsed in PBS, dehydrated in 75% ethanol 5 min, 90% ethanol 5 min, 100% ethanol 5 min and frozen. Prior to hybridization, cells were re-hydrated in PBS, 5 min. The slide was then incubated with PBS, 0.1% Triton X-100 at room temperature for 30 min, followed by PBS, 0.1% Triton X-100, normal goat serum 7% for 1 h and finally with anti-SPACA1 antibody (Atlas Antibodies AB) diluted 1:100 in PBS 0.1% Triton X-100, normal goat serum 3%, overnight. On the next day, the slide was rinsed in PBS, 0.1% Triton X-100, normal goat serum 3%, three times 10 min, and was incubated with an Alexa 488 conjugated goat anti-rabbit IgG antibody (Invitrogen) for 1 h. The slide was then washed twice for 10 min in PBS, 0.1% Triton X-100, before fixing in 4% paraformaldehyde, 1 × PBS for 10 min. Finally, the slide was washed, 10 min, in PBS, 0.1% Triton X-100 prior to staining with DAPI 25 ng/Ul diluted in Vectashield (Vector Laboratories, Abscys).
RT-PCR analysis of testis biopsies
Testis biopsies were collected within an ICSI protocol, and following laceration for testicular sperm retrieval, the biopsy material was recovered by centrifugation and the pellet stored in liquid nitrogen. Total RNA was extracted using the guanidinium/phenol method with TriPure (Roche). RNA was treated with RNase-free DNase (Roche) prior to converting it into cDNA. One microgram total RNA was converted into cDNA with Expand Reverse Transcriptase (Roche) in 20 ml. This was diluted to 200 and 1 ml used in PCR. Primers: DAZ o1625: gAAATCTGTGGACC-GAAGC and o1647: cCATGAAACTAGATAGCTG-548C; DAZL: o1625 and 1646: aTTTAAGCATTGCCCGACTTC-548C; EIF1AX/Y o1649: cAAAATGTTGGGAAATGGACG and o1650: tCATCATCATCTCCAG-GACC-608C; PRM1 o1680: tCATCATCATCTCCAGGACC and o1681: aGTCTGGTAACATTCTCAGGC-588C; PRM2 o2758: gACCCATGG CCAGTCTCACT and o1706: gGAAGCTTAGTGCCTTCTGC-588C, RBMY1 o2762: tACGGTGAGGCCCTTGGTAG and o2763: aTCACCA-CAGCTCGAGTAAC-608C; SYCP3 o2006: gCTTAACCAAGAATATTC TCAGCAG and o2007: cTTCCATACTCTTTATGAACTGCTC-608C; TNP1 o1713: aAATACCGTAAGGGCAACCTG and o1714: cCATAGG CTCCTCTCTGGC-588C; TNP2 o1715: aGAGGATCCAGCAGGTG TAC and o1716: cAAGCTTTAATTAGTGTTGCGTAG-588C.
Results
AZFb 1 c deletion in an oligozoospermic man At 29 years of age, the patient 13-1217 was oligozoospermic with a sperm count of 1 × 10 6 /ml, and 10% of spermatozoa were motile.
A further spermogram 1 year later gave a diagnosis of azoospermia, but from the morphological assessment of the cells present in the seminal fluid, it was concluded that some of the round cells could be spermatids. In the third semen analysis, in addition to round cells, one elongated cell with a short flagellum was observed, consistent with spermatogenesis continuing beyond meiosis in 13-1217. A part of the testicular biopsy used in attempts to recover mature spermatozoa for ICSI was subjected to immunofluorescent analysis with an antibody specific to the acrosomal protein SPACA1 (previously named SAMP32) (Hao et al., 2002) , revealing two cells with apparently welldeveloped acrosomes. The size and shape of both the nuclear and acrosomal staining of one of these cells (Spermatid 2 in Fig. 1 ) are consistent with those of an elongating spermatid. Routine screening for the classic AZF microdeletions unexpectedly revealed that 13-1217 carries an interstitial deletion of the Y chromosome resulting in the loss of the entire AZFb interval and most of the AZFc interval. The markers for which he is deleted (see the 'Material and Methods' section), in particular the four DAZ genes, and sY117 ( Fig. 2) demonstrate that patient 13-1217 has a P5/distal-P1 deletion (Repping et al., 2002) . He therefore presents an exceptional genotype-phenotype correlation: spermatogenesis associated with a deletion of the entire AZFb interval.
We therefore conducted a more in-depth characterization of 13-1217, in conjunction with two standard cases, 13-5349 and StE-363, in which a P5/proximal-P1 AZFb deletion is associated with the expected meiotic arrest phenotype (STS mapping detailed in the 'Material and Methods' section). The positions of the proximal breakpoints of these three cases were all mapped to P5, and are shown in Fig. 2 relative to the P5 spacer.
Defining the deletion breakpoints
Only one study has previously defined the breakpoints involved in AZFb deletions. These were precisely defined in 9 of 11 patients, all of whom were azoospermic (Repping et al., 2002) . In the case of 13-1217, we initially fine mapped deletion breakpoints to the P5 spacer (3.5 kb) and the proximal arm of P1.1 (Fig. 2 and data not  shown) . The presence of an intact palindrome arm at the AZFc end of the deletion, made further conventional STS mapping of the P1.1 breakpoint impossible. To circumvent this difficulty, we performed long-range PCRs with a primer (o1502) from the unique spacer of P1.1, oriented towards the centromere in the reference sequence, coupled with one of a series of primers distributed throughout the palindrome arm. Unexpectedly, all these PCRs were positive. An inversion of palindrome P1.1 has been reported, that effectively reverses the orientation of the central spacer (Repping et al., 2002) , and we therefore next performed PCR with a reverse-complement of the o1502 spacer primer (o1486). This gave different results with the most proximal primer, o1497, failing to give a product (Fig. 2) . This showed that P1.1 was indeed inverted on the Y chromosome of 13-1217's father, and localized the distal breakpoint to a 3.3 kb interval between the primer sites for o1499 (positive) and o1497 (negative), in the proximal arm of P1.1.
In order to precisely define the breakpoints, we isolated and sequenced the junction fragment. We PCR amplified the junction fragment using the primer o1278 from the proximal end of the P5 spacer and the primer o1504 derived from the non-deleted sequences of the proximal arm of P1.1. The primer o1504 overlaps but is complementary to o1499. This PCR amplified a fragment of 4.2 kb from 13-1217 only (Fig. 2) , which we sequenced directly to reveal a sharp transition from the P5 spacer (1479 bp from proximal end of spacer) to P1.1 (1781 bp from proximal end of P1.1) (Fig. 3) . Thus, 13-1217 carries a P5/distal-P1 deletion that did not arise by homologous recombination. Interestingly, this was previously demonstrated for one of seven P5/distal-P1 deletion cases, WHT3410, who like 13-1217 has a breakpoint within the P5 spacer and carries an inversion of P1.1 (Repping et al., 2002) .
Meiotic spreads
We have previously carried out meiotic studies on the AZFb-deleted patient 13-5349, and shown that while apparently normal synapsis was present in 29% of nuclei, spermatocytes rarely progressed beyond early pachytene stages (2/129). However in 59% of nuclei, synapsis was incomplete (12%) or limited/absent (47%) (Perrin et al., 2006) .
We analysed the progression of meiosis in 13-1217, using an antibody against SYCP3, a component of the SC. There were 69 wellspread nuclei analysed on one cytospin spot. Only three nuclei (4%) had apparently normal SC formation without fragmentation for 22 autosomal bivalents and one sex chromosome bivalent (Fig. 4) . The morphology of the sex vesicle in the three normal nuclei led us to conclude that these cells were at an early pachytene stage, Type I of Solari (Solari, 1980) . All other pachytene nuclei analysed showed abnormal SCs. The most frequent anomaly was SC fragmentation (Fig. 4) . Various degrees of bivalent fragmentation were observed, from nuclei with a few fragments to nuclei with complete fragmentation of all bivalents, giving a pulverized aspect to the bivalents. Importantly, fragmentation almost exclusively affected synapsed bivalents, and was rarely seen in asynapsed segments. In 15 nuclei, most SCs were generally of normal appearance but some (1 -5) were fragmented. In 21 nuclei, the SC of each bivalent was in multiple pieces, with some SCs having a dotted appearance in 6 of these nuclei (Fig. 4) and some SCs being elongated, stretched and discontinuous in 5 of these nuclei. Limited asynapsis was seen in five nuclei (not shown). Finally, in 25 nuclei, all SCs were completely pulverized. The sex chromosome axes could be tentatively identified in two of the less affected nuclei with fragmented bivalents, and showed the same early stage configuration found in the normal pachytene nuclei. In the other nuclei, the XY body could not be identified. The kinetochore number decreased in the more fragmented nuclei.
Of the 69 nuclei analysed, only 3 showed a normal nonfragmented SC configuration. The overall incidence of nuclei with fragmented bivalents was 96%. This frequency contrasted strongly with that observed in one fertile and eight infertile individuals. The incidence of nuclei with fragmented SCs in the normal control was only 6.2%. In the obstructive azoospermia group, this incidence varied from 6.9 to 18.2% with a mean of 14% and in the nonobstructive azoospermia group the incidence ranged from 8.1 to 46.2% with a mean of 17.6%. The fact that extensive asynapsis is rare in 13-1217 (0%), while it is frequent in 13-5349 (47%), is consistent with an exceptional progression of spermatogenesis in 13-1217, and suggests that 13-1217 does not manifest the meiotic block found in classic AZFb deletion cases.
Post-meiotic germ cell markers in an AZFb-deleted man
In order to confirm the presence of spermatids in the biopsy, we used RT -PCR to detect transcripts from genes expressed specifically in spermatids: genes coding protamine 1 and 2 (PRM1 and PRM2), and transition protein 1 (TNP1) (Steger et al., 1998 (Steger et al., , 2000 (Fig. 5) . The protamine genes were tested under semi-quantitative conditions by co-amplification with DAZL, which serves as a control of mitotic germ cell density within the biopsy, since DAZL is transcribed specifically at mitotic and early meiotic stages (Xu et al., 2001 ). These tests therefore give an indication of the efficiency with which mitotic germ cells are progressing to spermatids. Our tests reveal a clear difference between 13-1217 and the other AZFb deletion cases. Spliced PRM1 and TNP1 transcripts were detected in 13-1217 only, while PRM2 transcript levels were higher in 13-1217 than in the other AZFb cases. PRM2 expression has previously been similarly reported in an AZFb-deleted man (Friel et al., 2002) . This indicates that, in the human testis, PRM2 must be transcribed and spliced at low levels in a cell type other than the spermatid. The expression of these spermiogenesis markers is clearly much higher in the controls with complete spermatogenesis, where the protamine transcripts are so strongly amplified that they prevent the co-amplification of DAZL.
Tests with PRM1 and TNP1 alone confirmed these results and revealed the presence of an unspliced RNA in the AZFb biopsies (Fig. 5) . Compared with StE-363 and 13-5349, the increased intensity of the spliced form relative to the unspliced form, in 13-1217, is evidence that spermatids are present in this biopsy, although in greatly reduced numbers. Overall this is an indication that there is an exceptional progression of spermatogenesis beyond meiotic stages in the AZFb + c patient 13-1217.
No detectable mosiacism
The post-meiotic spermatogenesis of patient 13-1217 could depend on germ cells that carry an intact Y chromosome. To address this possibility, we studied DNA and RNA extracted from the same testicular biopsy for each of the three AZFb-deleted cases, 13-1217, 13-5349 and StE-363, and two men with obstructive azoospermia but complete spermatogenesis (Fig. 6) .
We tested for the presence of germ cells carrying an intact Y chromosome in the biopsy fragment by screening DNA and RNA for genes absent from the AZFb + c deleted Y chromosome carried by 13-1217: DAZ (AZFc) and EIF1AY and RBMY1 (AZFb). For expression tests an internal control was used, and DAZ was co-amplified with DAZL and EIF1AY with EIF1AX. We tested genomic DNA derived from the biopsy material by PCR with primers from DAZ intron 5/exon 6 (seven copies) and from RBMY1 (seven copies). None of these tests detected AZFb or AZFc material in 13-1217 (Fig. 6) . Thus, the presence of germ cells with an intact Y chromosome is an improbable explanation for the post-meiotic spermatogenesis in 13-1217. 
A rare Y haplogroup
If an allele of a gene on the Y chromosome outside the AZFb and AZFc interval underlies the exceptional meiotic phenotype, the 13-1217 Y chromosome would be more likely to be of a haplogroup that is infrequent in the Western European populations studied to establish the AZFb genotype -phenotype consensus. Using available Y chromosome binary markers, we have shown that the Y chromosomes of the two classic AZFb cases are Hg-J (13-5349) and , haplogroups that are frequent (12 and 24%, respectively) in our patient sample. In contrast, 13-1217 carries a Hg-L-M185 Y chromosome. This Y chromosome is rare in Western Europe, and we identified only two Hg-L Y chromosomes in 652 fertile control men from Marseille. In contrast, Hg-L has been found throughout the Indian sub-continent and reaches its highest frequencies in Pakistan (13%) (Sengupta et al., 2006) . The patient 13-1217 has a French surname and we have no evidence that he is of Asian origin. Although this is in no way proof that there is a modifier locus on the Hg-L Y chromosome, the finding of a geographically ectopic haplogroup in 13-1217 means that we cannot reject this hypothesis.
Discussion
The AZFb + c interstitial deletion case that we present here represents the first true exception to the genotype-phenotype correlations for the AZF deletions of the human Y chromosome established 13 years ago (Vogt et al., 1996) . While rare cases of multiple natural conception have been reported for men carrying AZFc deletions (Chang et al., 1999; Saut et al., 2000) , these are more probably explained by exceptionally high fertility of the female partner (Krausz and McElreavey, 2001) . Here, however, we demonstrate that spermatogenesis can progress beyond meiotic stages to produce haploid spermatids in the absence of the entire AZFb interval.
However, the failure to find testicular spermatozoa in 13-1217 appears to be an unexpected outcome, when a sperm count of 10 6 spermatozoa per ml was recorded only 1 year earlier. The exceptional nature of patient 13-1217 does, however, make it very difficult to Figure 5 Post-meitoic germ cell markers are transcribed in the testis of patient 13-1217 with a P5/P1-distal deletion. Results obtained for 13-1217 are compared with biopsies from two P5/ P1-proximal AZFb-deleted men, 13-5349 and StE-363, and two men, Ob1 and Ob2, with obstructive azoospermia and complete spermatogenesis. The upper three panels are the results of duplex RT -PCR amplifying DAZL plus either PRM1, PRM2 or TNP1. The lower two panels show RT-PCR for PRM1 and TNP1 individually. The asterisk indicates that the reverse transcription was oligo dT primed (13-5439 only), and all others were random primed. All PCRs are inter-exon. L, sizing ladder (1 kb plus, Invitrogen). The lowest rung shown is 100 bp. Figure 6 Screening for AZFb and AZFc markers in the AZFb + c-deleted patient 13-1217. EIF1AX, DAZL and SYCP3 served as positive controls for the RT -PCR. DNA and RNA were extracted from testicular biopsies, except the male and female control DNAs (blood). The AZFb and AZFc markers tested did not amplify by RT-PCR or PCR from the testicular biopsy of 13-1217. The asterisk indicates that the reverse transcription was oligo dT primed (13-5439 only), and all others were random primed. M, normal male; F, normal female; L, sizing ladder (1 kb plus, Invitrogen). The lowest rung shown is 100 bp. predict the evolution of his sperm production over time. Since 13-1217 is deleted for most of the AZFc interval as well as AZFb, informative comparisons may perhaps be made with men carrying the AZFc deletion. The AZFc deletion is associated with hypospermatogenesis, and it is therefore possible that 13-1217 has many testis tubules lacking post-meiotic germ cells. A similar decline in the sperm count, from around 10 7 spermatozoa per ml to azoospermia over a period of 10-30 months, has been described in some AZFcdeleted men (Girardi et al., 1997; Simoni et al., 1997) . Concerning the absence of testicular sperm in 13-1217, in a large study of 37 AZFc-deleted men , histological analysis of five oligozoospermic men showed no post-meiotic stages in any tubules. Thus, the failure to find spermatozoa in a random biopsy sample of testis tubules in 13-1217 may be consistent with the fact that he carries a large deletion of the AZFc interval. The meiotic profile of 13-1217 differs in several important aspects from that of the AZFb deletion case, 13-5349, and in fact more closely resembles that associated with the AZFc deletion (Geoffroy-Siraudin et al., 2007) . In 13-5349, spermatocytes are abundant and the anomaly most frequently observed is extended asynapsis (47%). In contrast, 13-1217, like AZFc-deleted cases has few meiotic germ cells and the major anomaly observed is SC fragmentation. Thus our results, together with those of our previous studies, suggest that 13-1217 does not show the compromised synapsis seen in a classic AZFb deletion case, but rather shares features found in AZFc-deleted cases, where germ cells progress beyond meiosis and complete spermatogenesis, albeit in reduced numbers. Thus in 13-1217, the SC fragmentation could be an indication that the spermatocytes are undergoing apoptosis as a secondary reaction to the decay of the seminiferous epithelium provoked by reduced germ cell numbers. The relatively low incidence of non-fragmented SC in 13-1217 could therefore be a consequence of increased apoptotic activity.
If the complete spermatogenesis of 13-1217 is linked to the presence of a critical AZFb factor, he would be expected to be deleted for less AZFb material than patients with maturation arrest. A comparison with published breakpoints (Repping et al., 2002) reveals that the deletion in 13-1217 removes a larger amount of P5 than four of the eight azoospermic men in whom the P5 breakpoint was defined. Informative comparisons with the published data are difficult, however, because no testicular phenotype is available for these men. In the case of our two P5/proximal-P1 patients (AZFb deletion) with confirmed maturation arrest, StE-363 has lost more of P5 than 13-1217, the proximal breakpoint being in the proximal arm of P5, while 13-5349 has lost less of P5, the breakpoint being in the distal arm of P5 (Fig. 2) . Since 13-5349 retains more of the AZFb interval than 13-1217, it is very unlikely that the retention of an AZFb interval gene could explain the exceptional progression of spermatogenesis in 13-1217. It remains possible, nevertheless, that the unique arrangement of sequences generated by the deletion in 13-1217 creates a position effect on an adjacent gene, such as CDY2, transcripts of which have been detected in biopsies from cases with a spermatocyte maturation arrest (Kleiman et al., 2003) . Our attempts to investigate this were inconclusive, however, as we were unable to detect CDY2 transcripts in any of the biopsies from AZFb deletion cases (M.J.M., unpublished data).
Based on our analyses, the most probable explanation for the association of post-meiotic spermatogenesis with an AZFb deletion, is the influence of a genetic or environmental factor reducing the stringency of the meiotic block induced by the AZFb deletion. The genetic factor could be anywhere in the genome, but it is nevertheless intriguing that 13-1217 carries a haplogroup L-M185 Y chromosome that is rare in the Western European and North American populations used to establish the AZF deletion phenotype-genotype correlations. The question of whether a Y-linked modifier locus is responsible should be resolved by Y microdeletion analysis in countries where the HgL Y chromosome is prevalent, such as Pakistan or India, or by the future identification and characterization, including Yhaplogroup typing, of further oligozoospermic AZFb cases.
The prognostic value of AZFb deletion testing is widely recognized; the detection of a complete AZFb deletion predicts the absence of testicular spermatozoa (Krausz et al., 2000) . The single AZFb + c deletion patient presented here does not affect the validity of this prognosis, but he does illustrate that exceptional cases could exist for whom testicular sperm retrieval would be a therapeutic option. An important reserve on our findings is obviously that they are derived from the study of only three AZFb deletion cases. It is now important to identify other such cases to allow the development of predictive tests. The tests that we have developed here, and in particular those for PRM1 and TNP1, should be a valuable phenotyping tool for the detection of post-meiotic germ cells, and thus may help identify other exceptional cases. These tests may also find a more general role in the evaluation of the post-meiotic progression of spermatogenesis in testicular biopsies that have failed to yield mature spermatozoa for ICSI.
